Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Research ArticleClinical Investigation

Nuclear Localization of 111In After Intravenous Injection of [111In-DTPA-D-Phe1]-Octreotide in Patients with Neuroendocrine Tumors

Eva Tiensuu Janson, Jan-Erik Westlin, Ulf Öhrvall, Kjell Öberg and Agneta Lukinius
Journal of Nuclear Medicine September 2000, 41 (9) 1514-1518;
Eva Tiensuu Janson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Erik Westlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf Öhrvall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kjell Öberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agneta Lukinius
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 9 1514-1518
PubMed 
10994731

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT© 2000 by the Society of Nuclear Medicine, Inc.

Author Information

Cited By...

  • 60 Citations
  • Google Scholar

Article usage

Article usage: February 2001 to February 2021

AbstractFullPdf
Feb 2001200
Mar 2001400
Apr 2001700
May 2001100
Jun 2001100
Jul 2001400
Aug 2001200
Sep 2001200
Oct 2001202
Dec 2001301
Jan 2002301
Feb 2002703
Apr 2002303
May 2002200
Jul 2002803
Aug 2002100
Sep 2002402
Oct 2002303
Nov 2002604
Dec 20021009
Jan 2003502
Feb 2003200
Mar 2003503
May 2003300
Jun 2003400
Jul 2003701
Aug 2003803
Sep 20031103
Oct 20031306
Nov 2003600
Dec 2003903
Jan 2004601
Feb 2004602
Mar 2004600
Apr 20041305
May 20041102
Jun 20042305
Jul 20042100
Aug 20041003
Sep 2004701
Oct 20041004
Nov 20041104
Dec 20041203
Jan 20051101
Feb 2005902
Mar 2005801
Apr 2005502
May 2005406
Jun 2005503
Jul 2005202
Aug 20051002
Sep 2005501
Oct 2005600
Nov 2005602
Dec 2005602
Jan 2006401
Feb 2006600
Mar 2006403
Apr 2006003
May 2006309
Jun 2006207
Jul 2006102
Aug 2006504
Sep 2006603
Oct 2006707
Nov 2006304
Dec 2006001
Jan 20076012
Feb 2007809
Mar 2007608
Apr 2007808
May 20079012
Jun 20071009
Jul 2007408
Aug 20076010
Sep 20074011
Oct 2007104
Nov 2007103
Dec 2007002
Jan 2008408
Feb 2008307
Mar 2008209
Apr 2008309
May 2008404
Jun 2008206
Jul 2008606
Aug 20082010
Sep 2008806
Oct 2008603
Nov 2008708
Dec 2008203
Jan 2009604
Feb 20094010
Mar 2009305
Apr 2009105
May 2009406
Jun 2009908
Jul 2009804
Aug 2009306
Sep 2009305
Oct 2009306
Nov 2009709
Dec 20094011
Jan 2010405
Feb 2010005
Mar 2010408
Apr 2010005
May 2010204
Jun 2010107
Jul 2010005
Aug 2010305
Sep 2010207
Oct 2010607
Nov 2010304
Dec 20109010
Jan 2011103
Feb 2011702
Mar 20116015
Apr 2011509
May 2011706
Jun 2011006
Jul 2011005
Aug 20110016
Sep 20110011
Oct 2011009
Nov 20110012
Dec 2011006
Jan 2012006
Feb 2012005
Mar 20120010
Apr 2012006
May 2012003
Jun 2012005
Jul 2012006
Aug 2012002
Sep 2012004
Oct 2012008
Nov 2012004
Dec 2012003
Jan 2013004
Feb 2013009
Mar 2013002
Apr 2013008
May 20130011
Jun 20130010
Jul 2013007
Aug 2013002
Sep 2013002
Oct 2013002
Nov 2013002
Dec 2013005
Jan 2014005
Feb 2014005
Mar 2014006
Apr 2014003
May 2014003
Jun 2014011
Jul 2014004
Aug 2014001
Sep 2014001
Oct 2014001
Nov 2014006
Dec 2014005
Jan 2015005
Feb 2015001
Mar 2015004
Apr 2015003
May 2015004
Jun 2015003
Jul 20150012
Aug 2015005
Sep 2015009
Nov 2015002
Dec 2015006
Jan 2016008
Feb 20160014
Mar 2016004
Apr 20160013
May 20160016
Jun 2016009
Jul 2016009
Aug 20160011
Sep 20160011
Oct 20160015
Nov 2016007
Dec 2016003
Jan 20170010
Feb 2017007
Mar 2017004
Apr 2017008
May 2017008
Jun 20170012
Jul 20170012
Aug 20170012
Sep 2017005
Oct 2017004
Nov 2017006
Dec 2017006
Jan 2018005
Feb 2018005
Mar 2018005
Apr 2018007
May 2018005
Jun 20180010
Jul 2018006
Aug 2018006
Sep 2018005
Oct 20180012
Nov 2018005
Dec 2018007
Jan 20190014
Feb 20190016
Mar 20190014
Apr 20190016
May 2019005
Jun 2019004
Jul 20190011
Aug 2019005
Sep 2019002
Dec 2019001
Jan 2020002
Feb 2020002
Mar 2020003
Apr 2020004
May 2020007
Jun 2020003
Aug 2020001
Sep 2020003
Oct 2020006
Nov 2020002
Dec 2020101
Jan 2021100
Feb 2021002
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 41, Issue 9
September 1, 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear Localization of 111In After Intravenous Injection of [111In-DTPA-D-Phe1]-Octreotide in Patients with Neuroendocrine Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Nuclear Localization of 111In After Intravenous Injection of [111In-DTPA-D-Phe1]-Octreotide in Patients with Neuroendocrine Tumors
Eva Tiensuu Janson, Jan-Erik Westlin, Ulf Öhrvall, Kjell Öberg, Agneta Lukinius
Journal of Nuclear Medicine Sep 2000, 41 (9) 1514-1518;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nuclear Localization of 111In After Intravenous Injection of [111In-DTPA-D-Phe1]-Octreotide in Patients with Neuroendocrine Tumors
Eva Tiensuu Janson, Jan-Erik Westlin, Ulf Öhrvall, Kjell Öberg, Agneta Lukinius
Journal of Nuclear Medicine Sep 2000, 41 (9) 1514-1518;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Molecular mechanisms of somatostatin receptor trafficking
  • Auger Electrons: Lethal, Low Energy, and Coming Soon to a Tumor Cell Nucleus Near You
  • Long-Term Efficacy of Radionuclide Therapy in Patients with Disseminated Neuroendocrine Tumors Uncontrolled by Conventional Therapy
  • Subcellular Localization of Radiolabeled Somatostatin Analogues: Implications for Targeted Radiotherapy of Cancer
  • Orbital Scintigraphy with the Somatostatin Receptor Tracer 99mTc-P829 in Patients with Graves' Disease
  • Cancer Therapy with Auger Electrons: Are We Almost There?
  • Peptide Receptor Radionuclide Therapy In Vitro Using [111In-DTPA0]Octreotide
  • Somatostatin Receptor Gene Expression in Human Ocular Tissues: RT-PCR and Immunohistochemical Study
  • Therapy of Disseminated B-Cell Lymphoma Xenografts in Severe Combined Immunodeficient Mice with an Anti-CD74 Antibody Conjugated with 111Indium, 67Gallium, or 90Yttrium
  • Google Scholar

More in this TOC Section

  • Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
  • German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
  • Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors
Show more Clinical Investigation

Similar Articles

SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire